Medicine and Dentistry
Adult
6%
Age
6%
Aminolevulinic Acid
16%
Analysis
27%
Assessment
7%
Atlas
6%
Baclofen
6%
Blood
7%
Bone
5%
Bone Tissue
6%
Brain Artery Aneurysm
6%
Brain Injury
6%
Brain Metastasis
15%
Brain Tumor
38%
Case Presentation
6%
Case Report
7%
Central Nervous System Tumor
6%
Combination Therapy
13%
Complication
13%
Contralateral
6%
Corticosteroid Therapy
6%
COVID-19
12%
Decompression Surgery
6%
Decompressive Craniectomy
6%
Diagnosis
17%
Disease Activity
6%
Dural Arteriovenous Fistula
6%
Epilepsy
6%
Epileptic Seizure
6%
Experience
18%
Facet Joint
6%
Follow up
5%
Ganglioglioma
13%
Glioblastoma
15%
Hematoma
5%
Hemosiderin
6%
Hernia
6%
Histopathology
6%
Hospital
8%
Hybrid
6%
Hypoxemia
7%
Hypoxia
10%
Incidence
10%
Injury
14%
Inpatient
17%
Isocitrate Dehydrogenase
6%
Learning
9%
Levetiracetam
6%
Lymphoma
7%
Magnetic Resonance Imaging
32%
Melanocytosis
6%
Meningioma
20%
Metabolism
9%
Metastatic Melanoma
6%
Microsurgery
6%
Mortality
6%
Mortality Rate
5%
Mutant
6%
Neoplasm
27%
Nerve Root
6%
Neurosurgery
11%
Neurosurgical Oncology
6%
Nodular Melanoma
6%
Oxygen
9%
Patient
100%
Pigmentation
6%
Pilocytic Astrocytoma
6%
Primary Central Nervous System Lymphoma
10%
Prognostic Factor
19%
Prophylaxis
6%
Pump
6%
Recurrent Disease
19%
Relative Survival
6%
Retrospective Study
7%
Skill
6%
Skin
6%
Soft Tissue
8%
Soft Tissue Tumor
6%
Spinal Hematoma
6%
Subdural Hematoma
8%
Surgery
29%
Therapeutic Procedure
16%
Therapy Delay
6%
Tissues
6%
Tumor Classification
6%
Tumor Microenvironment
6%
Neuroscience
Aminolevulinic Acid
14%
Aneurysm
6%
Brain
29%
Brain Injury
6%
Brain Tumor
22%
Coronavirus
6%
Decompressive Craniectomy
6%
DNA Methylation
7%
Epidural Hematoma
6%
Epilepsy
6%
Fluorescence
18%
Gene Mutation
6%
Glioma
7%
Hemosiderin
6%
Isocitrate Dehydrogenase
6%
Lymphoma
20%
Magnetic Resonance Imaging
14%
Magnetic Resonance Imaging
13%
Magnetoencephalography
6%
Meningioma
15%
Metastasis
24%
Neurosurgery
8%
Phenotype
8%
Pigmentation
6%
Pilocytic Astrocytoma
6%
Positron Emission Tomography
6%
Predictor
7%
Primary Central Nervous System Lymphoma
25%
Spinal Canal
6%
Subdural Hematoma
9%
Traumatic Brain Injury
12%
Biochemistry, Genetics and Molecular Biology
Anabolism
6%
Contrast
9%
DNA Methylation
12%
Experience
6%
Fluorescence
17%
Fluorescence Assay
6%
Hemosiderin
6%
Immune Response
6%
Learning
13%
Magnetic Resonance Imaging
30%
Messenger RNA
6%
Metabolic Pathway
10%
Metabolomics
6%
Mutant
6%
Neovascularization (Pathology)
11%
Oxidative Phosphorylation
6%
Phenotype
6%
Pigmentation
6%
Protein Expression
6%
Radiomics
13%
Sample
9%
Survival
5%
Thickness
6%
Time
9%
Tumor Classification
6%